Regardless of Resistance History, HIV Patients Saw High Viral Suppression With Dolutegravir

A dolutegravir-based regimen (ViiV Healthcare) is effective in suppressing viral loads in highly treatment-experienced HIV patients with resistant genotypes, according to a study from France.

In the first year after switching to a dolutegravir regimen, the 239 patients maintained a high level of viral suppression, even in those who had a genotypic susceptibility score (GSS) of 2 or less, according to Charlotte Charpentier, PhD, PharmD, and her colleagues, at Laboratoire de